Delaware
|
|
94-3180138
|
(State or other jurisdiction of
incorporation or organization)
|
|
(I.R.S. Employer
Identification No.)
|
Title of each class
|
Trading Symbol
|
Name of each exchange on which registered
|
Common Stock, $0.001 par value
|
IMMR
|
NASDAQ Global Market
|
Large accelerated filer
|
|
¨
|
|
Accelerated filer
|
|
ý
|
|
|
|
|
|||
Non-accelerated filer
|
|
¨(Do not check if a smaller reporting company)
|
|
Smaller Reporting Company
|
|
¨
|
|
|
|
|
Emerging Growth Company
|
|
¨
|
|
|
|
|
|
Page
|
|
|
|
|
||
|
|
|
|
||
|
|
|
|
||
|
|
|
|
||
|
|
|
|
||
|
|
|
|
||
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
September 30,
2019 |
|
December 31,
2018
|
||||
ASSETS
|
|
|
|
|
||||
Current assets:
|
|
|
|
|
||||
Cash and cash equivalents
|
|
$
|
86,585
|
|
|
$
|
110,988
|
|
Short-term investments
|
|
9,026
|
|
|
13,930
|
|
||
Accounts and other receivables
|
|
1,865
|
|
|
1,051
|
|
||
Prepaid expenses and other current assets
|
|
11,988
|
|
|
9,856
|
|
||
Total current assets
|
|
109,464
|
|
|
135,825
|
|
||
Property and equipment, net
|
|
1,768
|
|
|
2,343
|
|
||
Other assets, net
|
|
16,510
|
|
|
7,827
|
|
||
Total assets
|
|
$
|
127,742
|
|
|
$
|
145,995
|
|
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
|
|
|
|
||||
Current liabilities:
|
|
|
|
|
||||
Accounts payable
|
|
$
|
2,176
|
|
|
$
|
3,612
|
|
Accrued compensation
|
|
2,381
|
|
|
3,948
|
|
||
Other current liabilities
|
|
4,202
|
|
|
3,194
|
|
||
Deferred revenue
|
|
4,666
|
|
|
4,591
|
|
||
Total current liabilities
|
|
13,425
|
|
|
15,345
|
|
||
Long-term deferred revenue
|
|
26,816
|
|
|
30,203
|
|
||
Other long-term liabilities
|
|
3,072
|
|
|
787
|
|
||
Total liabilities
|
|
43,313
|
|
|
46,335
|
|
||
Contingencies (Note 12)
|
|
|
|
|
||||
Stockholders’ equity:
|
|
|
|
|
||||
Common stock and additional paid-in capital — $0.001 par value; 100,000,000 shares authorized; 38,618,922 and 37,652,498 shares issued, respectively; 31,795,775 and 30,829,351 shares outstanding, respectively
|
|
252,191
|
|
|
246,415
|
|
||
Accumulated other comprehensive income
|
|
132
|
|
|
116
|
|
||
Accumulated deficit
|
|
(119,544
|
)
|
|
(98,521
|
)
|
||
Treasury stock at cost: 6,823,147 and 6,823,147 shares, respectively
|
|
(48,350
|
)
|
|
(48,350
|
)
|
||
Total stockholders’ equity
|
|
84,429
|
|
|
99,660
|
|
||
Total liabilities and stockholders’ equity
|
|
$
|
127,742
|
|
|
$
|
145,995
|
|
|
Three months ended September 30,
|
|
Nine months ended September 30,
|
||||||||||||
|
2019
|
|
2018
|
|
2019
|
|
2018
|
||||||||
Revenues:
|
|
|
|
|
|
|
|
||||||||
Royalty and license
|
$
|
10,549
|
|
|
$
|
8,462
|
|
|
$
|
24,264
|
|
|
$
|
99,789
|
|
Development, services, and other
|
75
|
|
|
90
|
|
|
225
|
|
|
323
|
|
||||
Total revenues
|
10,624
|
|
|
8,552
|
|
|
24,489
|
|
|
100,112
|
|
||||
Costs and expenses:
|
|
|
|
|
|
|
|
||||||||
Cost of revenues
|
62
|
|
|
61
|
|
|
117
|
|
|
190
|
|
||||
Sales and marketing
|
1,688
|
|
|
1,664
|
|
|
4,876
|
|
|
4,454
|
|
||||
Research and development
|
1,933
|
|
|
2,110
|
|
|
6,066
|
|
|
7,152
|
|
||||
General and administrative
|
8,216
|
|
|
9,880
|
|
|
35,359
|
|
|
31,669
|
|
||||
Total costs and expenses
|
11,899
|
|
|
13,715
|
|
|
46,418
|
|
|
43,465
|
|
||||
Operating income (loss)
|
(1,275
|
)
|
|
(5,163
|
)
|
|
(21,929
|
)
|
|
56,647
|
|
||||
Interest and other income (loss)
|
(24
|
)
|
|
545
|
|
|
1,106
|
|
|
1,151
|
|
||||
Income (loss) before provision for income taxes
|
(1,299
|
)
|
|
(4,618
|
)
|
|
(20,823
|
)
|
|
57,798
|
|
||||
Provision for income taxes
|
(88
|
)
|
|
(22
|
)
|
|
(200
|
)
|
|
(313
|
)
|
||||
Net income (loss)
|
$
|
(1,387
|
)
|
|
$
|
(4,640
|
)
|
|
$
|
(21,023
|
)
|
|
$
|
57,485
|
|
Basic net income (loss) per share
|
$
|
(0.04
|
)
|
|
$
|
(0.15
|
)
|
|
$
|
(0.67
|
)
|
|
$
|
1.89
|
|
Shares used in calculating basic net income (loss) per share
|
31,711
|
|
|
30,780
|
|
|
31,461
|
|
|
30,340
|
|
||||
Diluted net income (loss) per share
|
$
|
(0.04
|
)
|
|
$
|
(0.15
|
)
|
|
$
|
(0.67
|
)
|
|
$
|
1.83
|
|
Shares used in calculating diluted net income (loss) per share
|
31,711
|
|
|
30,780
|
|
|
31,461
|
|
|
31,334
|
|
||||
Other comprehensive income
|
|
|
|
|
|
|
|
||||||||
Change in unrealized gains (loss) on short-term investments
|
(6
|
)
|
|
(2
|
)
|
|
16
|
|
|
8
|
|
||||
Total other comprehensive income
|
(6
|
)
|
|
(2
|
)
|
|
16
|
|
|
8
|
|
||||
Total comprehensive income (loss)
|
$
|
(1,393
|
)
|
|
$
|
(4,642
|
)
|
|
$
|
(21,007
|
)
|
|
$
|
57,493
|
|
|
Three Months Ended September 30, 2019
|
||||||||||||||||||||||||
|
Common Stock and
Additional Paid-In Capital |
|
Accumulated
Other Comprehensive Income |
|
Accumulated
Deficit |
|
Treasury Stock
|
|
Total
Stockholders’ Equity |
||||||||||||||||
|
Shares
|
|
Amount
|
|
|
Shares
|
|
Amount
|
|
||||||||||||||||
Balances at June 30, 2019
|
38,488,327
|
|
|
$
|
250,079
|
|
|
$
|
138
|
|
|
$
|
(118,157
|
)
|
|
6,823,147
|
|
|
$
|
(48,350
|
)
|
|
$
|
83,710
|
|
Net loss
|
|
|
|
|
|
|
(1,387
|
)
|
|
|
|
|
|
(1,387
|
)
|
||||||||||
Unrealized loss on available-for-sale securities, net of taxes
|
|
|
|
|
(6
|
)
|
|
|
|
|
|
|
|
(6
|
)
|
||||||||||
Issuance of stock for ESPP purchase
|
8,262
|
|
|
56
|
|
|
|
|
|
|
|
|
|
|
56
|
|
|||||||||
Exercise of stock options, net of shares withheld for employee taxes
|
111,333
|
|
|
869
|
|
|
|
|
|
|
|
|
|
|
869
|
|
|||||||||
Release of restricted stock units and awards
|
11,000
|
|
|
|
|
|
|
|
|
|
|
|
|
—
|
|
||||||||||
Stock based compensation
|
|
|
1,187
|
|
|
|
|
|
|
|
|
|
|
1,187
|
|
||||||||||
Balances at September 30, 2019
|
38,618,922
|
|
|
$
|
252,191
|
|
|
$
|
132
|
|
|
$
|
(119,544
|
)
|
|
6,823,147
|
|
|
$
|
(48,350
|
)
|
|
$
|
84,429
|
|
|
Three Months Ended September 30, 2018
|
||||||||||||||||||||||||
|
Common Stock and
Additional Paid-In Capital |
|
Accumulated
Other Comprehensive Income |
|
Accumulated
Deficit |
|
Treasury Stock
|
|
Total
Stockholders’ Equity |
||||||||||||||||
|
Shares
|
|
Amount
|
|
|
Shares
|
|
Amount
|
|
||||||||||||||||
Balances at June 30, 2018
|
37,488,535
|
|
|
$
|
240,445
|
|
|
$
|
109
|
|
|
$
|
(91,156
|
)
|
|
6,726,385
|
|
|
$
|
(47,441
|
)
|
|
$
|
101,957
|
|
Net loss
|
|
|
|
|
|
|
(4,640
|
)
|
|
|
|
|
|
(4,640
|
)
|
||||||||||
Unrealized loss on available-for-sale securities, net of taxes
|
|
|
|
|
(2
|
)
|
|
|
|
|
|
|
|
(2
|
)
|
||||||||||
Issuance of common stock for employee stock purchase
|
12,855
|
|
|
120
|
|
|
|
|
|
|
|
|
|
|
120
|
|
|||||||||
Exercise of stock options, net of shares withheld for employee taxes
|
4,687
|
|
|
31
|
|
|
|
|
|
|
|
|
|
|
31
|
|
|||||||||
Release of restricted stock units and awards
|
20,833
|
|
|
|
|
|
|
|
|
|
|
|
|
|
—
|
|
|||||||||
Stock based compensation
|
|
|
2,514
|
|
|
|
|
|
|
|
|
|
|
2,514
|
|
||||||||||
Effect of change in accounting policy
|
|
|
|
|
|
|
417
|
|
|
|
|
|
|
417
|
|
||||||||||
Balances at September 30, 2018
|
37,526,910
|
|
|
$
|
243,110
|
|
|
$
|
107
|
|
|
$
|
(95,379
|
)
|
|
6,726,385
|
|
|
$
|
(47,441
|
)
|
|
$
|
100,397
|
|
|
Nine Months Ended September 30, 2019
|
|
|
||||||||||||||||||||||
|
Common Stock and
Additional Paid-In Capital |
|
Accumulated
Other Comprehensive Income |
|
Accumulated
Deficit |
|
Treasury Stock
|
|
Total
Stockholders’ Equity |
||||||||||||||||
|
Shares
|
|
Amount
|
|
|
Shares
|
|
Amount
|
|
||||||||||||||||
Balances at December 31, 2018
|
37,652,498
|
|
|
$
|
246,415
|
|
|
$
|
116
|
|
|
$
|
(98,521
|
)
|
|
6,823,147
|
|
|
$
|
(48,350
|
)
|
|
$
|
99,660
|
|
Net loss
|
|
|
|
|
|
|
(21,023
|
)
|
|
|
|
|
|
(21,023
|
)
|
||||||||||
Unrealized gain on available-for-sale securities, net of taxes
|
|
|
|
|
16
|
|
|
|
|
|
|
|
|
16
|
|
||||||||||
Issuance of stock for ESPP purchase
|
21,741
|
|
|
165
|
|
|
|
|
|
|
|
|
|
|
165
|
|
|||||||||
Exercise of stock options, net of shares withheld for employee taxes
|
173,131
|
|
|
1,240
|
|
|
|
|
|
|
|
|
|
|
1,240
|
|
|||||||||
Release of restricted stock units and awards
|
771,552
|
|
|
|
|
|
|
|
|
|
|
|
|
—
|
|
||||||||||
Stock based compensation
|
|
|
4,371
|
|
|
|
|
|
|
|
|
|
|
4,371
|
|
||||||||||
Balances at September 30, 2019
|
38,618,922
|
|
|
$
|
252,191
|
|
|
$
|
132
|
|
|
$
|
(119,544
|
)
|
|
6,823,147
|
|
|
$
|
(48,350
|
)
|
|
84,429
|
|
|
Nine Months Ended September 30, 2018
|
||||||||||||||||||||||||
|
Common Stock and
Additional Paid-In Capital |
|
Accumulated
Other Comprehensive Income |
|
Accumulated
Deficit |
|
Treasury Stock
|
|
Total
Stockholders’ Equity |
||||||||||||||||
|
Shares
|
|
Amount
|
|
|
Shares
|
|
Amount
|
|
||||||||||||||||
Balances at December 31, 2017
|
35,950,518
|
|
|
$
|
228,046
|
|
|
$
|
99
|
|
|
$
|
(171,616
|
)
|
|
6,686,690
|
|
|
$
|
(46,872
|
)
|
|
$
|
9,657
|
|
Net income
|
|
|
|
|
|
|
57,485
|
|
|
|
|
|
|
57,485
|
|
||||||||||
Unrealized gain on available-for-sale securities, net of taxes
|
|
|
|
|
8
|
|
|
|
|
|
|
|
|
8
|
|
||||||||||
Issuance of common stock for employee stock purchase
|
26,689
|
|
|
218
|
|
|
|
|
|
|
|
|
|
|
218
|
|
|||||||||
Exercise of stock options, net of shares withheld for employee taxes
|
1,326,718
|
|
|
8,580
|
|
|
|
|
|
|
39,695
|
|
|
(569
|
)
|
|
8,011
|
|
|||||||
Release of restricted stock units and awards
|
222,985
|
|
|
|
|
|
|
|
|
|
|
|
|
—
|
|
||||||||||
Stock based compensation
|
|
|
6,266
|
|
|
|
|
|
|
|
|
|
|
6,266
|
|
||||||||||
Effect of change in accounting policy (1)
|
|
|
|
|
|
|
18,752
|
|
|
|
|
|
|
18,752
|
|
||||||||||
Balances at September 30, 2018
|
37,526,910
|
|
|
$
|
243,110
|
|
|
$
|
107
|
|
|
$
|
(95,379
|
)
|
|
6,726,385
|
|
|
$
|
(47,441
|
)
|
|
$
|
100,397
|
|
|
|
Nine Months Ended September 30,
|
||||||
|
|
2019
|
|
2018
|
||||
Cash flows provided by (used in) operating activities:
|
|
|
|
|
||||
Net income (loss)
|
|
$
|
(21,023
|
)
|
|
$
|
57,485
|
|
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
|
|
|
|
|
||||
Depreciation and amortization
|
|
588
|
|
|
647
|
|
||
Stock-based compensation
|
|
4,371
|
|
|
6,266
|
|
||
Foreign currency translation loss
|
|
361
|
|
|
—
|
|
||
Deferred income taxes
|
|
105
|
|
|
67
|
|
||
Other
|
|
1
|
|
|
26
|
|
||
Changes in operating assets and liabilities:
|
|
|
|
|
||||
Accounts and other receivables
|
|
(814
|
)
|
|
(454
|
)
|
||
Prepaid expenses and other current assets
|
|
(2,239
|
)
|
|
(1,870
|
)
|
||
Other assets
|
|
(9,849
|
)
|
|
(3,910
|
)
|
||
Accounts payable
|
|
(1,440
|
)
|
|
(5,889
|
)
|
||
Accrued compensation
|
|
(1,567
|
)
|
|
(1,560
|
)
|
||
Other current liabilities
|
|
(15
|
)
|
|
1,807
|
|
||
Deferred revenue
|
|
(3,312
|
)
|
|
22,713
|
|
||
Other long-term liabilities
|
|
3,967
|
|
|
211
|
|
||
Net cash provided by (used in) operating activities
|
|
(30,866
|
)
|
|
75,539
|
|
||
Cash flows provided by investing activities:
|
|
|
|
|
||||
Purchases of short-term investments
|
|
(8,930
|
)
|
|
(17,693
|
)
|
||
Proceeds from maturities of short-term investments
|
|
14,000
|
|
|
22,000
|
|
||
Purchases of property and equipment
|
|
(12
|
)
|
|
(63
|
)
|
||
Net cash provided by investing activities
|
|
5,058
|
|
|
4,244
|
|
||
Cash flows provided by financing activities:
|
|
|
|
|
||||
Proceeds from issuance of common stock under employee stock purchase plan
|
|
165
|
|
|
218
|
|
||
Proceeds from stock options exercises
|
|
1,240
|
|
|
8,010
|
|
||
Net cash provided by financing activities
|
|
1,405
|
|
|
8,228
|
|
||
Net increase (decrease) in cash and cash equivalents
|
|
(24,403
|
)
|
|
88,011
|
|
||
Cash and cash equivalents:
|
|
|
|
|
||||
Beginning of period
|
|
110,988
|
|
|
24,622
|
|
||
End of period
|
|
$
|
86,585
|
|
|
$
|
112,633
|
|
Supplemental disclosure of cash flow information:
|
|
|
|
|
||||
Cash paid for income taxes
|
|
$
|
104
|
|
|
$
|
139
|
|
Supplemental disclosure of non-cash operating, investing, and financing activities:
|
|
|
|
|
||||
Release of restricted stock units and awards under company stock plan
|
|
$
|
7,148
|
|
|
$
|
2,806
|
|
•
|
Performance Obligation A: to transfer rights to the Company's patent portfolio as it exists when the contract is executed;
|
•
|
Performance Obligation B: to transfer rights to the Company's patent portfolio as it evolves over the term of the contract, including access to new patent applications that the licensee can benefit from over the term of the contract.
|
|
Three Months Ended September 30,
|
|
Nine Months Ended September 30,
|
||||||||||||
|
2019
|
|
2018
|
|
2019
|
|
2018
|
||||||||
Fixed fee license revenue
|
$
|
4,115
|
|
|
$
|
4,317
|
|
|
$
|
10,109
|
|
|
$
|
81,955
|
|
Per-Unit royalty revenue
|
6,434
|
|
|
4,145
|
|
|
14,155
|
|
|
17,834
|
|
||||
Total royalty and license revenue
|
10,549
|
|
|
8,462
|
|
|
24,264
|
|
|
99,789
|
|
||||
Development, services, and other revenue
|
75
|
|
|
90
|
|
|
225
|
|
|
323
|
|
||||
Total revenues
|
$
|
10,624
|
|
|
$
|
8,552
|
|
|
$
|
24,489
|
|
|
$
|
100,112
|
|
|
|
September 30, 2019
|
|
|
||||||||||||
|
|
Fair Value Measurements Using
|
|
|
||||||||||||
|
|
Quoted Prices
in Active Markets for Identical Assets (Level 1) |
|
Significant
Other Observable Inputs (Level 2) |
|
Significant
Unobservable Inputs (Level 3) |
|
Total
|
||||||||
Assets:
|
|
|
|
|
|
|
|
|
||||||||
Money market accounts
|
|
$
|
63,226
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
63,226
|
|
U.S. Treasury securities
|
|
—
|
|
|
9,026
|
|
|
—
|
|
|
9,026
|
|
||||
Total assets at fair value (1)
|
|
$
|
63,226
|
|
|
$
|
9,026
|
|
|
$
|
—
|
|
|
$
|
72,252
|
|
|
|
December 31, 2018
|
|
|
||||||||||||
|
|
Fair Value Measurements Using
|
|
|
||||||||||||
|
|
Quoted Prices
in Active
Markets for
Identical Assets
(Level 1) |
|
Significant
Other Observable Inputs (Level 2) |
|
Significant
Unobservable Inputs (Level 3) |
|
Total
|
||||||||
Assets:
|
|
|
|
|
|
|
|
|
||||||||
Money market accounts
|
|
$
|
81,425
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
81,425
|
|
U.S. Treasury securities
|
|
—
|
|
|
13,930
|
|
|
—
|
|
|
13,930
|
|
||||
Total assets at fair value (2)
|
|
$
|
81,425
|
|
|
$
|
13,930
|
|
|
$
|
—
|
|
|
$
|
95,355
|
|
|
|
September 30, 2019
|
||||||||||||||
|
|
Amortized
Cost |
|
Gross
Unrealized Holding Gains |
|
Gross
Unrealized Holding Losses |
|
Fair
Value |
||||||||
U.S. Treasury securities
|
|
$
|
9,016
|
|
|
$
|
10
|
|
|
$
|
—
|
|
|
$
|
9,026
|
|
Total
|
|
$
|
9,016
|
|
|
$
|
10
|
|
|
$
|
—
|
|
|
$
|
9,026
|
|
|
|
December 31, 2018
|
||||||||||||||
|
|
Amortized
Cost |
|
Gross
Unrealized Holding Gains |
|
Gross
Unrealized Holding Losses |
|
Fair
Value |
||||||||
U.S. Treasury securities
|
|
$
|
13,936
|
|
|
$
|
—
|
|
|
$
|
(6
|
)
|
|
$
|
13,930
|
|
Total
|
|
$
|
13,936
|
|
|
$
|
—
|
|
|
$
|
(6
|
)
|
|
$
|
13,930
|
|
|
|
September 30,
2019 |
|
December 31,
2018 |
||||
Trade accounts receivable
|
|
$
|
1,485
|
|
|
$
|
645
|
|
Other receivables
|
|
380
|
|
|
406
|
|
||
Accounts and other receivables
|
|
$
|
1,865
|
|
|
$
|
1,051
|
|
|
|
September 30,
2019 |
|
December 31,
2018 |
||||
Contract assets - long-term
|
|
$
|
6,033
|
|
|
$
|
7,231
|
|
Lease assets
|
|
3,371
|
|
|
—
|
|
||
Deferred tax assets
|
|
295
|
|
|
295
|
|
||
Other assets
|
|
6,811
|
|
|
301
|
|
||
Total other assets, net
|
|
$
|
16,510
|
|
|
$
|
7,827
|
|
|
September 30,
2019 |
|
December 31,
2018 |
||||
Accrued legal
|
$
|
1,453
|
|
|
$
|
1,827
|
|
Lease liabilities - current
|
1,161
|
|
|
—
|
|
||
Income taxes payable
|
228
|
|
|
204
|
|
||
Other current liabilities
|
1,360
|
|
|
1,163
|
|
||
Total other current liabilities
|
$
|
4,202
|
|
|
$
|
3,194
|
|
|
|
September 30,
2019 |
|
Common stock shares available for grant
|
|
3,172
|
|
Standard and market condition-based stock options outstanding
|
|
2,011
|
|
RSAs outstanding
|
|
91
|
|
RSUs outstanding
|
|
949
|
|
|
|
Number of Shares
Underlying Stock Options |
|
Weighted Average
Exercise Price Per Share |
|
Weighted Average
Remaining Contractual Life (Years) |
|
Aggregate
Intrinsic Value |
|||||
Outstanding at December 31, 2018
|
|
1,862
|
|
|
$
|
9.44
|
|
|
2.85
|
|
$
|
751
|
|
Granted
|
|
783
|
|
|
$
|
8.25
|
|
|
|
|
|
||
Exercised
|
|
(173
|
)
|
|
$
|
7.16
|
|
|
|
|
|
||
Canceled or expired
|
|
(733
|
)
|
|
$
|
9.78
|
|
|
|
|
|
||
Outstanding as of September 30, 2019
|
|
1,739
|
|
|
$
|
8.98
|
|
|
3.35
|
|
$
|
128
|
|
Vested and expected to vest at September, 2019
|
|
1,739
|
|
|
$
|
8.98
|
|
|
3.35
|
|
$
|
128
|
|
Exercisable at September 30, 2019
|
|
927
|
|
|
$
|
9.57
|
|
|
0.52
|
|
$
|
10
|
|
|
|
Number of Restricted Stock Units
|
|
Weighted Average Grant Date Fair Value
|
|
Weighted Average
Remaining Contractual Life (Years) |
|
Aggregate
Intrinsic Value |
|||||
Outstanding at December 31, 2018
|
|
1,091
|
|
|
$
|
10.97
|
|
|
0.67
|
|
$
|
9,773
|
|
Granted
|
|
864
|
|
|
$
|
8.57
|
|
|
|
|
|
|
|
Released
|
|
(709
|
)
|
|
$
|
11.32
|
|
|
|
|
|
|
|
Forfeited
|
|
(297
|
)
|
|
$
|
9.84
|
|
|
|
|
|
|
|
Outstanding at September 30, 2019
|
|
949
|
|
|
$
|
8.88
|
|
|
1.47
|
|
$
|
7,259
|
|
|
|
Number of Restricted Stock Awards
|
|
Weighted Average Grant Date Fair Value
|
|
Weighted Average Remaining Recognition Period
(Years) |
|||
Outstanding at December 31, 2018
|
|
55
|
|
|
$
|
13.02
|
|
|
0.46
|
Granted
|
|
114
|
|
|
$
|
7.06
|
|
|
|
Released
|
|
(62
|
)
|
|
$
|
12.63
|
|
|
|
Forfeited
|
|
(16
|
)
|
|
$
|
7.27
|
|
|
|
Outstanding at September 30, 2019
|
|
91
|
|
|
$
|
7.45
|
|
|
0.70
|
|
|
Three Months Ended
September 30, |
|
Nine Months Ended
September 30, |
||||||||||||
|
|
2019
|
|
2018
|
|
2019
|
|
2018
|
||||||||
Stock options
|
|
$
|
200
|
|
|
$
|
286
|
|
|
$
|
516
|
|
|
$
|
960
|
|
RSUs and RSAs
|
|
971
|
|
|
2,206
|
|
|
3,798
|
|
|
5,234
|
|
||||
Employee stock purchase plan
|
|
16
|
|
|
22
|
|
|
57
|
|
|
72
|
|
||||
Total
|
|
$
|
1,187
|
|
|
$
|
2,514
|
|
|
$
|
4,371
|
|
|
$
|
6,266
|
|
|
|
|
|
|
|
|
|
|
||||||||
Sales and marketing
|
|
$
|
207
|
|
|
$
|
377
|
|
|
$
|
700
|
|
|
$
|
675
|
|
Research and development
|
|
234
|
|
|
561
|
|
|
1,054
|
|
|
1,382
|
|
||||
General and administrative
|
|
746
|
|
|
1,576
|
|
|
2,617
|
|
|
4,209
|
|
||||
Total
|
|
$
|
1,187
|
|
|
$
|
2,514
|
|
|
$
|
4,371
|
|
|
$
|
6,266
|
|
|
|
Unrealized Gains & Losses on Available for Sale Securities
|
|
Foreign Currency Items
|
|
Total
|
||||||
Balance as of June 30, 2019
|
|
$
|
16
|
|
|
$
|
122
|
|
|
$
|
138
|
|
Amounts reclassified from accumulated other comprehensive income
|
|
(6
|
)
|
|
—
|
|
|
(6
|
)
|
|||
Net current period other comprehensive income
|
|
(6
|
)
|
|
—
|
|
|
(6
|
)
|
|||
Balance as of September 30, 2019
|
|
$
|
10
|
|
|
$
|
122
|
|
|
$
|
132
|
|
|
|
Unrealized Gains & Losses on Available for Sale Securities
|
|
Foreign Currency Items
|
|
Total
|
||||||
Balance as of December 31, 2018
|
|
$
|
(6
|
)
|
|
$
|
122
|
|
|
$
|
116
|
|
Amounts reclassified from accumulated other comprehensive income
|
|
16
|
|
|
—
|
|
|
16
|
|
|||
Net current period other comprehensive income
|
|
16
|
|
|
—
|
|
|
16
|
|
|||
Balance as of September 30, 2019
|
|
$
|
10
|
|
|
$
|
122
|
|
|
$
|
132
|
|
|
Three Months Ended
September 30, |
|
Nine Months Ended
September 30, |
||||||||||||
|
2019
|
|
2018
|
|
2019
|
|
2018
|
||||||||
Income (loss) before provision for income taxes
|
$
|
(1,299
|
)
|
|
$
|
(4,618
|
)
|
|
$
|
(20,823
|
)
|
|
$
|
57,798
|
|
Provision for income taxes
|
$
|
(88
|
)
|
|
$
|
(22
|
)
|
|
$
|
(200
|
)
|
|
$
|
(313
|
)
|
Effective tax rate
|
(6.8
|
)%
|
|
(0.5
|
)%
|
|
(1.0
|
)%
|
|
0.5
|
%
|
|
|
Three Months Ended
September 30, |
|
Nine Months Ended
September 30, |
||||||||||||
|
|
2019
|
|
2018
|
|
2019
|
|
2018
|
||||||||
Numerator:
|
|
|
|
|
|
|
|
|
||||||||
Net income (loss)
|
|
$
|
(1,387
|
)
|
|
$
|
(4,640
|
)
|
|
$
|
(21,023
|
)
|
|
$
|
57,485
|
|
Denominator:
|
|
|
|
|
|
|
|
|
||||||||
Weighted-average common stock outstanding, basic
|
|
31,711
|
|
|
30,780
|
|
|
31,461
|
|
|
30,340
|
|
||||
Dilutive effect of potential common shares:
|
|
|
|
|
|
|
|
|
||||||||
Stock options, RSUs, RSA and ESPP
|
|
—
|
|
|
—
|
|
|
—
|
|
|
994
|
|
||||
Total shares, diluted
|
|
31,711
|
|
|
30,780
|
|
|
31,461
|
|
|
31,334
|
|
||||
Basic net income (loss) per share
|
|
$
|
(0.04
|
)
|
|
$
|
(0.15
|
)
|
|
$
|
(0.67
|
)
|
|
$
|
1.89
|
|
Diluted net income (loss) per share
|
|
$
|
(0.04
|
)
|
|
$
|
(0.15
|
)
|
|
$
|
(0.67
|
)
|
|
$
|
1.83
|
|
|
|
September 30
|
||||
|
|
2019
|
|
2018
|
||
Standard and market condition-based stock options outstanding
|
|
2,011
|
|
|
2,323
|
|
RSUs outstanding
|
|
949
|
|
|
1,091
|
|
RSAs outstanding
|
|
91
|
|
|
63
|
|
|
Balance Sheets Classification
|
|
September 30, 2019
|
|
January 1, 2019
|
||||
Assets
|
|
|
|
|
|
||||
Operating lease assets
|
Other assets
|
|
$
|
3,371
|
|
|
$
|
4,048
|
|
Liabilities
|
|
|
|
|
|
||||
Operating lease liabilities - current
|
Other current liabilities
|
|
1,161
|
|
|
1,157
|
|
||
Operating lease liabilities - long-term
|
Other long-term liabilities
|
|
2,921
|
|
|
3,693
|
|
||
Total lease liabilities
|
|
|
$
|
4,082
|
|
|
$
|
4,850
|
|
Cash paid within operating cash flow
|
|
$
|
878
|
|
Weighted average lease terms (in years)
|
|
3.60
|
|
|
Three Months Ended
September 30, |
|
|
|||||||||||
|
2019
|
|
2018
|
|
$ Change
|
|
% Change
|
|||||||
Revenues:
|
|
|
|
|
|
|
|
|||||||
Fixed fee license revenue
|
$
|
4,115
|
|
|
$
|
4,317
|
|
|
$
|
(202
|
)
|
|
(5
|
)%
|
Per-unit royalty revenue
|
6,434
|
|
|
4,145
|
|
|
2,289
|
|
|
55
|
%
|
|||
Total royalty and license revenue
|
10,549
|
|
|
8,462
|
|
|
2,087
|
|
|
25
|
%
|
|||
Development, services, and other revenue
|
75
|
|
|
90
|
|
|
(15
|
)
|
|
(17
|
)%
|
|||
Total revenues
|
$
|
10,624
|
|
|
$
|
8,552
|
|
|
$
|
2,072
|
|
|
24
|
%
|
|
Nine Months Ended
September 30, |
|
|
|||||||||||
|
2019
|
|
2018
|
|
$ Change
|
|
% Change
|
|||||||
Revenues:
|
|
|
|
|
|
|
|
|||||||
Fixed fee license revenue
|
$
|
10,109
|
|
|
$
|
81,955
|
|
|
$
|
(71,846
|
)
|
|
(88
|
)%
|
Per-unit royalty revenue
|
14,155
|
|
|
17,834
|
|
|
(3,679
|
)
|
|
(21
|
)%
|
|||
Total royalty and license revenue
|
$
|
24,264
|
|
|
99,789
|
|
|
(75,525
|
)
|
|
(76
|
)%
|
||
Development, services, and other revenue
|
225
|
|
|
323
|
|
|
(98
|
)
|
|
(30
|
)%
|
|||
Total revenues
|
$
|
24,489
|
|
|
$
|
100,112
|
|
|
$
|
(75,623
|
)
|
|
(76
|
)%
|
|
Three Months Ended
September 30, |
|
|
|
|
|||||||||
|
2019
|
|
2018
|
|
Change
|
|
% Change
|
|||||||
Sales and marketing
|
$
|
1,688
|
|
|
$
|
1,664
|
|
|
$
|
24
|
|
|
1
|
%
|
% of total revenue
|
16
|
%
|
|
19
|
%
|
|
|
|
|
|||||
Research and development
|
$
|
1,933
|
|
|
$
|
2,110
|
|
|
$
|
(177
|
)
|
|
(8
|
)%
|
% of total revenue
|
18
|
%
|
|
25
|
%
|
|
|
|
|
|||||
General and administrative
|
$
|
8,216
|
|
|
$
|
9,880
|
|
|
$
|
(1,664
|
)
|
|
(17
|
)%
|
% of total revenue
|
77
|
%
|
|
116
|
%
|
|
|
|
|
|
Nine Months Ended
September 30, |
|
|
|
|
|||||||||
|
2019
|
|
2018
|
|
Change
|
|
% Change
|
|||||||
Sales and marketing
|
$
|
4,876
|
|
|
$
|
4,454
|
|
|
$
|
422
|
|
|
9
|
%
|
% of total revenue
|
20
|
%
|
|
4
|
%
|
|
|
|
|
|||||
Research and development
|
$
|
6,066
|
|
|
$
|
7,152
|
|
|
$
|
(1,086
|
)
|
|
(15
|
)%
|
% of total revenue
|
25
|
%
|
|
7
|
%
|
|
|
|
|
|||||
General and administrative
|
$
|
35,359
|
|
|
$
|
31,669
|
|
|
$
|
3,690
|
|
|
12
|
%
|
% of total revenue
|
144
|
%
|
|
32
|
%
|
|
|
|
|
|
|
Three Months Ended
September 30, |
|
|
|||||||||||
|
|
2019
|
|
2018
|
|
Change
|
|
% Change
|
|||||||
Loss before provision for income taxes
|
|
$
|
(1,299
|
)
|
|
$
|
(4,618
|
)
|
|
|
|
|
|||
Provision for income taxes
|
|
(88
|
)
|
|
(22
|
)
|
|
$
|
(66
|
)
|
|
300
|
%
|
||
Effective tax rate
|
|
(6.8
|
)%
|
|
(0.5
|
)%
|
|
|
|
|
|
|
Nine Months Ended
September 30, |
|
|
|||||||||||
|
|
2019
|
|
2018
|
|
Change
|
|
% Change
|
|||||||
Income (loss) before provision for income taxes
|
|
$
|
(20,823
|
)
|
|
$
|
57,798
|
|
|
|
|
|
|||
Provision for income taxes
|
|
(200
|
)
|
|
(313
|
)
|
|
$
|
113
|
|
|
(36
|
)%
|
||
Effective tax rate
|
|
(1.0
|
)%
|
|
0.5
|
%
|
|
|
|
|
|
|
Nine Months Ended
September 30, |
||||||
|
|
2019
|
|
2018
|
||||
Net cash (used in) provided by operating activities
|
|
$
|
(30,866
|
)
|
|
$
|
75,539
|
|
Net cash provided by investing activities
|
|
$
|
5,058
|
|
|
$
|
4,244
|
|
Net cash provided by financing activities
|
|
$
|
1,405
|
|
|
$
|
8,228
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exhibit
Number
|
|
Exhibit Description
|
|
Incorporated by Reference
|
|
Filed
Herewith
|
||||||
|
|
Form
|
|
File No.
|
|
Exhibit
|
|
Filing Date
|
|
|||
|
|
|
|
|
|
|
|
|
|
X
|
||
|
|
|
|
|
|
|
|
|
|
X
|
||
|
|
|
|
|
|
|
|
|
|
X
|
||
|
|
|
|
|
|
|
|
|
|
X
|
||
|
|
|
|
|
|
|
|
|
|
X
|
||
101.INS
|
|
XBRL Report Instance Document
|
|
|
|
|
|
|
|
|
|
X
|
101.SCH
|
|
XBRL Taxonomy Extension Schema Document
|
|
|
|
|
|
|
|
|
|
X
|
101.CAL
|
|
XBRL Taxonomy Calculation Linkbase Document
|
|
|
|
|
|
|
|
|
|
X
|
101.DEF
|
|
XBRL Taxonomy Extension Definition Linkbase Document
|
|
|
|
|
|
|
|
|
|
X
|
101.LAB
|
|
XBRL Taxonomy Label Linkbase Document
|
|
|
|
|
|
|
|
|
|
X
|
101.PRE
|
|
XBRL Presentation Linkbase Document
|
|
|
|
|
|
|
|
|
|
X
|
*
|
This certification is deemed not filed for purposes of section 18 of the Exchange Act, as amended, or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act, as amended, or the Exchange Act, as amended.
|
†
|
Portions of this exhibit have been redacted in compliance with Regulation S-K Item 601(b)(10).
|
|
|
IMMERSION CORPORATION
|
|
||
|
|
|
|
||
Date:
|
November 7, 2019
|
By:
|
/s/ LEN WOOD
|
||
|
|
|
Len Wood
|
||
|
|
|
Interim Chief Financial Officer
|
|
|
/s/ RAMZI HAIDAMUS
|
|
Ramzi Haidamus
|
|
Chief Executive Officer
|
|
|
|
/s/ LEN WOOD
|
|
Len Wood
|
|
Interim Chief Financial Officer
|
|
|
|
/s/ RAMZI HAIDAMUS
|
|
Ramzi Haidamus
|
|
Chief Executive Officer
|
|
|
|
/s/ LEN WOOD
|
|
Len Wood
|
|
Interim Chief Financial Officer
|
|